SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results
Key Highlights
- ➤Third-quarter revenue $59 million, up 35% year-over-year
- ➤Adjusted EBITDA $28 million, up 66%; margin expanded to 47%
- ➤Net income attributable to SBC Medical $16 million, up 22% year-over-year
- ➤Clinic network reached 293 locations, up 36 year-over-year
- ➤Cash and equivalents $198 million; Net Cash totaled $154 million
Expert Statements
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“The third quarter of 2026 marked a strong reacceleration in SBC Medical’s growth.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Revenue increased 35% year-over-year, income from operations rose 66%, and net income attributable to SBC Medical rose 22%, with a net income margin of 27% and an Adjusted EBITDA(1) margin of 47%.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Following the structural reforms implemented in 2025, growth and profitability are improving in tandem, demonstrating the strength of our highly profitable MSO model.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Our MSO revenue growth is supported by two key levers: expanding our clinic network and increasing service fees per clinic.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Our goal is not simply to add locations. We aim to raise productivity and profitability at the clinics we support while expanding the network efficiently.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“This quarter’s growth in management services revenue, including the effect of service fee revisions, demonstrates progress in this model.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“To strengthen this model further, we are investing in AI and technology.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Specifically, we are developing a proprietary local large language model (LLM) infrastructure designed to enable the secure use of medical data while optimizing AI costs, while also advancing our clinic operating systems through our capital and business alliance with Atomic Software.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Together, these initiatives are intended to improve profitability at existing clinics and make new clinic openings more efficient, enabling our scalable MSO platform to generate greater earnings power as the business expands.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Our Longevity business, which we view as our next growth opportunity, is also making tangible progress.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“As a first step, we are developing an in-house DNA methylation-based test to estimate biological age, drawing on the Waqoo Group’s research and technology capabilities.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“By adding diagnostics to our existing medical network and combining AI with physicians’ expertise, we aim to build an integrated platform spanning testing, personalized treatment and evaluation of outcomes.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“In Japan, we will continue expanding our multi-brand presence in aesthetic dermatology and broadening our non-aesthetic medical services.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“Internationally, we are pursuing collaboration with OrangeTwist in the United States and expansion across ASEAN markets.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“These initiatives are designed to unlock further growth in our existing business while pursuing opportunities in new markets.”
Yoshiyuki Aikawa, Chairman and CEO of SBC Medical
“We intend to deploy this strong financial position toward disciplined growth investment, with the goal of sustaining EPS growth over the medium- to long-term and enhancing corporate value.”
SBC Medical Group Holdings Reports Third Quarter 2026 Financial Results
Revenue Up 35%, Net Income Attributable to SBC Medical Up 22%, and Adjusted EBITDA(1) Up 66% Year-over-Year; Net Income Margin of 27% and Adjusted EBITDA Margin of 47% — Previously Announced Service Fee Revisions and New Clinic Openings Contribute to Revenue Growth and Operating Margin Improvement
Get started
Create a free account to read the full story.